ANTI-CANCER DRUG 润色咨询

ANTI-CANCER DRUGS

出版年份:1990 年文章数:1990 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2021-07-19 ms5563413869182965

    投稿以后,需要通讯作者登录邮箱确认吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2016-04-17 ms9285292773773234

    审稿速度:3.0
    经验分享:一月份投稿
    三月一审要求大修,其实只有三个审稿意见,不需要补实验
    四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回
    四月15号接收
    总的来说还是很快的,编辑态度也很和蔼

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2016-07-03 啦啦啦啦啦啦啦啦啦啦

    文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2021-06-01 ms3000000371005110

    这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2021-01-08 1215c911m91暂无昵称

    with editor好久了

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2020-12-18 liuchao6688

    Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?
    anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2019-12-12 周打杂

    你好,现请问现在变了吗littlebug123 2019-08-14 09:53:00 发表:
    Initial Date Submitted: Jul 17 2019 9:53:51:947PM
    Status Date :Jul 18 2019 4:04:57:593AM
    Current Status: With Editor
    一个多月了,状态一直没变啊

    littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM
    Status Date :Jul 18 2019 4:04:57:593AM
    Current Status: With Editor
    一个多月了,状态一直没变啊

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2020-05-12 yxiao527

    你投的有结果了么?!134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:
    这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流

    134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2020-05-12 yxiao527

    你投的有结果了么?2655153056_38631572 2019-12-31 00:00:00 发表:
    您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你

    2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1000757, encodeId=cc2d1000e57f1, content=投稿以后,需要通讯作者登录邮箱确认吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48341897674, createdName=ms5563413869182965, createdTime=Mon Jul 19 01:57:44 CST 2021, time=2021-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=831989, encodeId=874c83198919, content=审稿速度:3.0<br>经验分享:一月份投稿<br> 三月一审要求大修,其实只有三个审稿意见,不需要补实验<br> 四月初修回,四月十几号二审要求小修,修改几处格式,一天后修回<br> 四月15号接收<br> 总的来说还是很快的,编辑态度也很和蔼 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Sun Apr 17 09:15:47 CST 2016, time=2016-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524440, encodeId=25f652444054, content=文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krol2enhljkLEgayt1UialCicQEZFI6eLzkibr1xI8UHqdn16vPrqmLKUG5NP3B66Phwfl77QLV94d5v/0, createdBy=ead51743461, createdName=啦啦啦啦啦啦啦啦啦啦, createdTime=Sun Jul 03 18:24:00 CST 2016, time=2016-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970159, encodeId=62d99e0159a9, content=这个杂志OA的审稿+版面费3595刀,非OA的版面费有哪位同仁知道是多少钱吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c0f5429996, createdName=ms3000000371005110, createdTime=Tue Jun 01 20:25:09 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914724, encodeId=ca8a914e2414, content=with editor好久了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Fri Jan 08 20:41:30 CST 2021, time=2021-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909129, encodeId=6f7e909129fd, content=Did you or your institution at any time receive payment or support in kind for any aspect of the submitted work (including but not limited to grants, consulting fee or honorarium, support for travel to meetings for the study or other purposes, fees for participation in review activities such as data monitoring boards, statistical analysis, end point committees, and the like, payment for writing or reviewing the manuscript, provision of writing assistance, medicines, equipment, or administrative support, etc...)?<br>anti-cancer drugs 投稿中这个是选yes 还是no? 哪位大神知道啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f52c5442991, createdName=liuchao6688, createdTime=Fri Dec 18 15:28:03 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581373, encodeId=8bf05813e3ff, content=你好,现请问现在变了吗<span class="quote">littlebug123 2019-08-14 09:53:00 发表:<br>Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊</span>, beContent=littlebug123 2019-08-14 09:53:00 发表: Initial Date Submitted: Jul 17 2019 9:53:51:947PM <br> Status Date :Jul 18 2019 4:04:57:593AM <br> Current Status: With Editor <br> 一个多月了,状态一直没变啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/13/a143fd154fc1971181ee7a5981a53567.jpg, createdBy=b3f25160591, createdName=周打杂, createdTime=Thu Dec 12 00:00:00 CST 2019, time=2019-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590713, encodeId=0b2d590e13ec, content=你投的有结果了么?!<span class="quote">134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表:<br>这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流</span>, beContent=134UGSc0543(暂无昵称) 2020-03-13 00:15:00 发表: 这个杂志快的话两三个月接受(good manuscript),慢的话要5-9个月,paper格式改的让人有点抓狂,而且已经发表的文章让人有点嫌弃,很多都是黑白图,而且abstract那里排版很不齐。投后只能慢慢等了。欢迎交流, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590714, encodeId=5c68590e1434, content=你投的有结果了么?<span class="quote">2655153056_38631572 2019-12-31 00:00:00 发表:<br>您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你</span>, beContent=2655153056_38631572 2019-12-31 00:00:00 发表: 您好,我跟你之前的的情况是一样的。查询文章状态,上面都显示为0。我看到有建议登录通讯作者的账号里面查。我想问,因为我当时投的时候,只注册了自己的账号,通讯作者是我的导师,我没有帮她注册,那怎么登她的账号。想请教你, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Tue May 12 00:00:00 CST 2020, time=2020-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589106, encodeId=f6df5891061a, content=请问接受后多久可以上线检索到呀?!<span class="quote">啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:<br>文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位</span>, beContent=啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/fc1qqUhicx1JAQqwojQ9nWnYGL26lDsdkGQu9HSlSCtYIxFv8qSVXpibuOQZqnqn2DyseX8by4u6iaCFxQEMS9XBQ/132, createdBy=5dfc2298459, createdName=yxiao527, createdTime=Fri Apr 17 00:00:00 CST 2020, time=2020-04-17, status=1, ipAttribution=)]
    2020-04-17 yxiao527

    请问接受后多久可以上线检索到呀?!啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表:
    文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位

    啦啦啦啦啦啦啦啦啦啦 2016-07-03 18:24:00 发表: 文章2月5号投出的,由于种种原因,未按照杂志要求的格式投出,甚至完全是按照自己的格式投出的,投出后正在过年的时候,也没看状态,心想肯定会被拒的,但是后来开电脑看状态的时候变成under review了,这时候挺开心了,感觉不会因为格式问题被拒了。在3月3日,收到杂志的意见为“Accept pending major revision,The idea is novel. The project is well designed and carried out.",一共7个问题,感觉是只有一个审稿人,因为不想补实验,每个问题都找到说法,3月15号提交回去,4月14号回复说我给回的不是那么令人满意,但是最后让我一定要补个实验,我就补了,4月25号再次提交,期间催了一个,最终5月18号接收,也终于赶在末班车前可以拿学位

    0

共170条页码: 4/17页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分